$SPRC

$5.50▲ -4.8% YTD

2 SEC 13D/G filings tracked · Last updated Sep 2, 2026

Filing History

CP $5.50▲ -4.8%Sep 2, 2026 · ThinkSabio Blog

$SPRC - SciSparc: Subsidiary NeuroThera Labs Pursues FDA Orphan Drug Designation For Adult Tourette Syndrome Drug; Engages Government and Public Affai…

News

SPRC ▼ -2.6% - SciSparc Ltd.

CP $6.41▲ -2.6%Aug 31, 2026 · ThinkSabio Blog

$SPRC - SciSparc: Subsidiary NeuroThera Labs Achieves Significant Enrollment Momentum in SCI?210 Autism Clinical Trial…